{"nct_id":"NCT04155190","title":"An Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas in Patients With Non-Gorlin High Frequency BCC","status":"TERMINATED","status_verified_date":"2023-05","start_date":"2019-12-20","start_date_type":"ACTUAL","primary_completion_date":"2021-04-23","primary_completion_date_type":"ACTUAL","completion_date":"2021-04-23","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["SLGL"]}